SOMAI PHARMACEUTICALS LTD
Somai Pharmaceuticals LTD is a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal and distribution of EU GMP-certified cannabinoid-containing pharmaceuticals throughout the European Union and globally. Somai emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system, effectively and with consistency across all markets. Somai's product development knowledge was honed in the competitive American m... arket, and is the largest and most advanced cannabinoid manufacturing facility across legal European markets producing medicines products and registered API's. Somai has brought together an all-star team of scientists and KOL's from around the world with various clinical experiences to guide Somai's product development and acceptance globally. Somai stresses education and continual R&D, which started from the USA as transformative developments, to help EU doctors and patients properly diagnose and treat the individual indications by providing variable dosage choices. Somaiโs primary goal is producing the most advanced products with the most innovative delivery methods to create maximum bioavailability and healing for patients. Somai is fast becoming one of the most recognized and well-developed pharmaceutical brands in the EU. As a global biotech player concentrating on cannabinoids, Somai has a unique pipeline of current and future products that will be on the market starting in late 2022. They already boast one of the largest IP (Intellectual Property) vaults of APIs that werenโt accessible to Europe until recently. Somaiโs near term products conform to the highest standards of herbal medicine (ACM) and specialized cannabinoid APIโs for R&D, but also keeps a steady eye on the horizon of future clinical trials for their proprietary pipeline, setting it up to be well positioned for the next decade.
SOMAI PHARMACEUTICALS LTD
Industry:
Biopharma Biotechnology Cannabis Pharmaceutical
Founded:
2019-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.somaipharma.eu
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.somaipharma.eu Semrush global rank: 9.94 M Semrush visits lastest month: 77
- Host name: 164.92.225.181
- IP address: 164.92.225.181
- Location: Denver United States
- Latitude: 39.7277
- Longitude: -104.9815
- Metro Code: 751
- Timezone: America/Denver
- Postal: 80203

More informations about "Somai Pharmaceuticals Ltd"
Início - SOMAÍ Pharmaceuticals
A SOMAÍ Pharmaceuticals é uma empresa europeia líder de mercado, integrada verticalmente e com certificação EU-GMP, com uma pegada global de distribuição da maior e mais avançada โฆSee details»
SOMAÍ Pharmaceuticals โ Cannabis Industry Council
SOMAÍ Pharmaceuticals is a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP โฆSee details»
Home - SOMAÍ Pharmaceuticals
May 27, 2025 SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest โฆSee details»
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and
Sep 1, 2023 SOMAÍ Pharmaceuticals LTD is a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal, and distribution of EU GMP-certified โฆSee details»
Home - SOMAÍ Pharmaceuticals - somaipharma.co.uk
SOMAu00cd Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most โฆSee details»
Somai Pharmaceuticals - Craft
See insights on Somai Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About us - SOMAÍ Pharmaceuticals
Our FacilitiesOur state-of-the-art extraction and cultivation facilities power SOMAÍโs high-quality flower and pharmaceutical product lines.See details»
SOMAÍ Pharmaceuticals - Crunchbase Company Profile & Funding
SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global footprint of distribution for the largest and most advanced EU GMP-certified โฆSee details»
SOMAÍ Pharmaceuticals: recent developments in the โฆ
Sep 15, 2023 SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, focusing on the highest quality medical-grade uses. They separate and purify primary bulk APIs of cannabinoids such THC, THCa, โฆSee details»
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises โฆ
Jul 29, 2024 SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for โฆSee details»
SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility
Sep 27, 2022 In addition to their new facility, SOMAÍ Pharmaceuticals is delivering a focused marketing program headed by a Top 40 pharmaceutical marketing agency, Solaris Health. โฆSee details»
Investor relations - SOMAÍ Pharmaceuticals
Nov 28, 2023 The company had raised 22,3 mln EUR from several private investors and private equity firms. Also SOMAÍ successfully qualified for the grant of 2,1 mln EUR from the Portugal โฆSee details»
SOMAÍ Pharmaceuticals Receives EU-GMP Certification
SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for its facility located in โฆSee details»
Investor relations - SOMAÍ Pharmaceuticals
Investor relations Investor Summary SOMAÍ Pharmaceuticals is a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the โฆSee details»
Our facilities - SOMAÍ Pharmaceuticals - somaipharma.eu
SOMAÍ Pharmaceuticals Extraction facility NovaSoma Cultivation facilitySee details»
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises โฆ
Sep 1, 2023 SOMAÍ Pharmaceuticals LTD is a European pharmaceutical and biotech company centered on manufacturing in Lisbon, Portugal, and distribution of EU GMP-certified โฆSee details»
Investor relations - SOMAÍ Pharmaceuticals - somaipharma.ie
Nov 28, 2023 The company had raised 22,3 mln EUR from several private investors and private equity firms. Also SOMAÍ successfully qualified for the grant of 2,1 mln EUR from the Portugal โฆSee details»
SOMAÍ Pharmaceuticals erhält EU-GMP-Zertifizierung und โฆ
SOMAÍ Pharmaceuticals Unipessoal LDA, der größte europäische Hersteller pharmazeutischer Cannabisprodukte, freut sich bekannt zu geben, dass er von der portugiesischen โฆSee details»
EU and Germany push for a new World Trade Organization
2 days ago Brussels and Berlin have launched a new initiative aimed at bypassing the long-standing paralysis of the World Trade Organization, as caused by the United States. But how โฆSee details»
Our formulations - SOMAÍ Pharmaceuticals
Our FacilitiesOur state-of-the-art extraction and cultivation facilities power SOMAÍโs high-quality flower and pharmaceutical product lines.See details»